Old Web
English
Sign In
Acemap
>
Paper
>
P33.11 Immunotherapy Outcomes in KRAS Mutated vs KRAS Wild-Type Advanced Lung Adenocarcinoma
P33.11 Immunotherapy Outcomes in KRAS Mutated vs KRAS Wild-Type Advanced Lung Adenocarcinoma
2021
D. Collons
R Nguyen
M. Khan
C. Schwartz
M. Pasquinelli
L. Feldman
Keywords:
KRAS
Immunotherapy
Lung
Cancer research
Wild type
Medicine
Adenocarcinoma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]